Israel VC Funds

Hippocrates VC is a physician-backed venture capital firm specializing in digital health startups. With a focus on impact-driven investments, they aim to transform healthcare delivery through innovative technologies. Notable portfolio companies include Fruit Street, which provides diabetes prevention via telehealth, and Avive AED, developing life-saving tools for sudden cardiac arrest. Smiley Scope, another investment, uses VR to improve patient outcomes. Their geographic focus is primarily the U.S., and they target startups that can scale globally. Hippocrates seeks early-stage ventures, often leading rounds with an average check size of $500k to $2M. They prefer companies at the intersection of healthcare and technology, especially those offering digital therapeutics or telemedicine solutions. The fund is led by Laurence Girard, a healthcare entrepreneur who previously raised over $40M for his ventures. Under his leadership, Hippocrates maintains a strong network of physician investors, creating a unique ecosystem for healthcare innovation. To approach the fund, startups are encouraged to demonstrate clear clinical impacts and a solid path to commercialization, especially within regulated healthcare markets.

Hive Data, also known as The Hive, is a Palo Alto-based venture fund and co-creation studio dedicated to launching AI-driven startups with an emphasis on data science, blockchain, and other advanced technologies. As both investor and hands-on collaborator, Hive Data engages early-stage startups through a high-touch model, providing pre-seed and seed capital (typically between $1.5 million to $3 million) alongside extensive support in product development, go-to-market strategies, and securing additional funding. The Hive focuses on enterprise applications across sectors like digital health, fintech, insurance, and industrials, targeting innovative solutions in areas such as machine learning, computer vision, and ambient intelligence. They also foster an innovation ecosystem through The Hive Think Tank, a prominent thought-leadership community that connects AI and data professionals in the Bay Area and beyond. This platform brings together corporations, startups, and investors, offering events, resources, and networking opportunities, and includes partners like IBM, Microsoft, and Cloudera. The Hive operates globally with separate funds in regions including Brazil, India, and Southeast Asia, expanding their collaborative model of company-building across multiple continents. Key team members, like T.M. Ravi and Sumant Mandal, bring deep expertise from Silicon Valley and beyond, leveraging backgrounds in tech leadership and venture capital to guide their portfolio companies through early growth stages.

Hong Kong Science and Technology Parks Corporation (HKSTP) is the leading innovation and technology (I&T) ecosystem in Hong Kong. Established in 2001, HKSTP fosters tech startups and industry growth, focusing on sectors like healthtech, AI and robotics, fintech, and smart city innovations. The corporation manages a network that includes the Hong Kong Science Park, InnoCentre, and InnoParks, supporting over 1,700 companies and 14,000 R&D professionals. HKSTP offers full-cycle support to startups, from incubation and prototyping to funding and commercialization. They manage the HKSTP Venture Fund, a HK$1 billion asset fund, to support high-growth tech ventures, and have groomed multiple unicorns within their ecosystem. With strong connections to the Greater Bay Area, HKSTP also helps companies expand into mainland China. Their resources include world-class R&D labs, co-working spaces, advanced manufacturing centers, and a broad investor network. HKSTP’s mission is to drive collaboration, accelerate innovation, and cultivate talent for Hong Kong and the broader region, positioning the city as a leading global innovation hub.

HOF Capital is a global venture capital firm headquartered in New York, focused on investing in transformative technology companies from idea to IPO. With support from over 70 influential family offices, global corporations, and institutions, HOF provides startups with more than just capital—they offer strategic partnerships that open doors to new markets, customer bases, and operational growth. Their portfolio features industry-leading companies such as Alibaba, Epic Games, UiPath, and ASAPP. HOF Capital specializes in sectors like fintech, deep tech, healthcare, and logistics, making investments from pre-seed to late-stage rounds. The firm’s approach emphasizes long-term value creation, guiding entrepreneurs through various growth stages with business development, sales, and fundraising support. With offices in New York, London, and San Francisco, and a team of investors spread across key global regions, HOF operates as a bridge between startups and large-scale enterprises. Co-founded by Hisham Elhaddad, Onsi Sawiris, and Fady Yacoub, HOF leverages its vast network of partners, including industry giants like Visa, Nvidia, and Daimler, to provide startups with critical resources and strategic advice. Their multi-stage investment strategy, combined with deep industry knowledge and a vast network, helps startups scale quickly while navigating complex challenges in highly competitive environments.

HP Tech Ventures, established in 2016, is the venture capital arm of HP Inc., designed to fuel innovation by strategically investing in early-stage startups that are poised to disrupt the tech landscape. The firm’s investment focus spans a variety of high-impact areas, including generative AI, edge computing, hybrid work solutions, 3D printing, and sustainability. These sectors align with HP's broader vision of shaping the future through transformative technologies. HP Tech Ventures not only provides capital but also offers its portfolio companies access to HP’s global resources, including one of the world’s largest channel and distribution networks, deep technological expertise, and a vast manufacturing and supply chain infrastructure. This support helps startups scale rapidly and achieve significant market impact. The firm’s portfolio is diverse, including companies like Mojo Vision, a pioneer in micro-LED technology, and Owl Labs, which focuses on solutions for hybrid work environments. HP Tech Ventures has also seen successful exits, such as the acquisition of Mobalytics, a gaming analytics platform, by Tencent, and Voxel8, a 3D printing startup, by DSM. These exits demonstrate HP Tech Ventures' ability to identify and nurture companies that deliver substantial returns and technological advancements. The team at HP Tech Ventures, led by Andrew Bolwell, Angelo Del Priore, and others, brings extensive experience in both the technology and venture capital sectors. They actively engage with portfolio companies, offering strategic guidance and leveraging HP’s vast network to accelerate growth. With investments primarily in the U.S. and Israel, HP Tech Ventures continues to be a key player in driving innovation across the tech industry.

Hubraum, Deutsche Telekom's tech incubator, is dedicated to fostering innovation in 5G, AI, IoT, and other advanced technologies by bridging the gap between early-stage startups and the extensive resources of Deutsche Telekom. Established in 2012, Hubraum operates from Berlin, Krakow, and Tel Aviv, providing startups with access to mentorship, investment, and Deutsche Telekom's extensive networks, clients, and technology. Hubraum has made over 50 investments, focusing primarily on pre-seed, seed, and Series A stages. Their portfolio includes notable companies like Blinkist, Relayr, and TEXEL, with recent investments in Salvador Technologies and Phelas. These investments highlight Hubraum’s commitment to supporting cutting-edge innovations in various tech sectors including IoT, big data, and AI. The incubator not only offers financial backing but also provides free coworking space and a robust support system to help startups scale their businesses. This comprehensive approach ensures that startups have the necessary resources and guidance to succeed in a competitive tech landscape. Through these initiatives, Hubraum plays a crucial role in driving technological advancement and creating new business opportunities​.

Hummingbird VC, founded in 2010 and based in Antwerp, Belgium, is an early-stage venture capital firm that invests globally, backing founders with groundbreaking ideas. The firm has a strong portfolio with notable investments in companies like Deliveroo, Kraken, and Peak Games. Hummingbird VC focuses on a wide array of industries including fintech, biotech, deep tech, healthcare, and marketplaces, with investments across North America, EMEA, and APAC regions. Hummingbird's investment strategy centers on partnering early with outlier founders and providing unwavering support through the company's lifecycle. They are known for their high conviction and willingness to make substantial investments, often leading funding rounds with check sizes ranging from $500K to over $50M. They prefer a low-friction partnership approach, allowing entrepreneurs to dictate the level of involvement and support needed. Key figures in the team include Barend Van den Brande, the founder, who is based in Belgium, and other partners spread across their international offices. Hummingbird is noted for its patient capital and long-term support, especially during challenging times for startups. They emphasize radical candor and dedication to the founders they back, aiming to foster transformative growth and industry disruption.

Hydra Ventures is the corporate venture arm of Adidas, based in Amsterdam, Netherlands. Established in 2011, Hydra Ventures focuses on investing in companies that develop new consumer brands and trends, particularly in the areas of apparel, footwear, and sports-related technologies. Backed by the full support of Adidas, Hydra Ventures seeks to identify and nurture innovative companies that align with the broader strategic goals of Adidas, particularly in areas related to lifestyle and athletic performance. The firm operates with a focus on fostering new consumer experiences and tapping into emerging markets that have the potential to influence the future of sports and fashion. By investing in early-stage companies, Hydra Ventures aims to drive growth in the sports and lifestyle sectors, helping startups scale and integrate with Adidas’ broader ecosystem. Hydra Ventures plays a strategic role in helping Adidas stay at the forefront of innovation in the highly competitive sportswear industry by enabling the development of cutting-edge technologies and new business models. Through its investments, Hydra Ventures not only supports the growth of its portfolio companies but also strengthens Adidas’ market position by leveraging the innovations and consumer insights generated by these ventures.

i3 Equity Partners, established in 2017 and based in Tel Aviv, is a venture capital firm focused on seed-stage investments in Israeli startups. The firm specializes in the Internet of Things (IoT) sector, supporting companies that are developing cutting-edge technologies in areas like smart cities, industrial IoT, and advanced manufacturing. i3 Equity Partners is backed by a consortium of global industry leaders, including Tel Aviv University, Pitango Venture Capital, Microsoft Ventures, and others, providing startups with not just capital but also strategic guidance and access to a broad network of industry connections. i3 Equity Partners has a strong track record in identifying and nurturing early-stage startups, offering them the resources needed to accelerate time to market and scale internationally. The firm typically invests in companies that demonstrate strong technological innovation and potential for global impact. In addition to financial backing, i3 Equity Partners is deeply involved in mentoring and supporting the growth of its portfolio companies, making it a vital player in Israel's tech ecosystem.

ICONIQ Capital, a multifaceted investment management firm headquartered in San Francisco, manages over $80 billion in assets. The firm is known for serving influential families and organizations, particularly those in technology, high finance, and entertainment sectors. ICONIQ has a robust portfolio featuring investments in prominent tech companies. Notable portfolio companies include Airbnb, Alibaba, Facebook, Snowflake, and Uber. They also have significant stakes in innovative firms like OpenAI, HashiCorp, and Miro, showcasing their focus on transformative technologies and scalable business models. Their investment strategy involves partnering with inspired entrepreneurs to drive industry transformation. ICONIQ Capital provides not only financial support but also strategic guidance, leveraging their extensive network to foster growth and innovation. The firm operates globally with offices in New York, London, and Hong Kong, offering a comprehensive range of services including private equity, venture capital, real estate, and philanthropic advisory. ICONIQ's team comprises experienced professionals like Divesh Makan, one of the founders, who bring deep expertise and a hands-on approach to managing investments and advising clients.

iGan Partners is a leading venture capital firm based in Toronto, Canada, specializing in early-stage investments in technology and healthcare sectors. Founded in 1999, iGan Partners has built a strong portfolio by partnering with innovative startups and helping them scale their disruptive technologies. The firm has a diverse portfolio that includes companies like Think Research, a provider of clinical content and technology solutions; MolecuLight, which develops imaging devices for wound care; and eSight, known for creating electronic glasses that improve vision for the legally blind. Other notable investments include MedChart, a platform that enables businesses to access and exchange patient-authorized digital health information, and Cosm Medical, which designs medical devices for personalized pelvic health solutions. iGan Partners typically invests in seed and Series A rounds, with a focus on companies in the healthcare sector, including medical devices, digital health, and health IT. They have been involved in funding rounds for companies like Hyivy Health and Curv Health, supporting innovative solutions in personal health and wellness. The firm is led by a team of experienced professionals, including Founder and Managing Partner Sam Ifergan and Chief Medical Officer Dr. Lorena Tora. Their extensive expertise in healthcare and technology enables them to provide valuable support and strategic guidance to their portfolio companies​.

iGlobe Partners, founded in 1999 and headquartered in Singapore, is a prominent venture capital firm with a global investment strategy. The firm focuses on early to growth-stage investments in tech-driven sectors such as smart cities, synthetic biology, and fintech. iGlobe Partners has a strong track record of investing in transformative companies and has managed funds exceeding USD 500 million​. Their diverse portfolio includes notable companies such as Matterport, which provides AI-powered 3D data platforms to create digital twins of physical spaces, and NerdWallet, a popular personal finance company. Additionally, they have invested in C2i Genomics, a leader in cloud-based cancer diagnostics, and Twist Bioscience, which is revolutionizing DNA synthesis. iGlobe Partners' investment approach emphasizes collaboration with top-tier scientific and entrepreneurial talent to drive innovation. The firm has been instrumental in scaling game-changing companies across the U.S., Europe, and Asia, leveraging its extensive global network to support portfolio companies in expanding their market reach​. With the recent close of their USD 100 million iGlobe Platinum Fund III, the firm continues to invest in high-growth areas, particularly focusing on innovations in healthcare, logistics, and smart city technologies. This strategic focus aims to capitalize on the accelerated adoption of technology driven by the COVID-19 pandemic, promising substantial returns in the long term.

Impact Venture is a London-based family office with a strong focus on early-stage investments that drive positive social and environmental impact. Their portfolio includes groundbreaking companies like Mango Materials, which produces biodegradable plastics, and Cadence Health, a U.S.-based firm revolutionizing access to over-the-counter birth control. Impact Venture backs startups in sectors like health, sustainability, and tech-driven solutions, including vertical farming and synthetic biology. Geographically, they prioritize investments in regions where these technologies can address large-scale global challenges. Their approach combines patient capital with a hands-on partnership, emphasizing long-term relationships and follow-on funding to help ventures scale successfully. Impact Venture typically provides early-stage funding between £100,000 and £500,000 and invests in bold leaders using advanced technologies to solve urgent societal issues. The firm’s strategy is underpinned by a strong belief in measurable outcomes—both financial and impact-driven—and they prefer startups with strong scientific or technological foundations. The CEO, Kateryna Filippi, leads the team from London, bringing deep expertise in supporting ventures that are reshaping industries​.

Imprimatur Capital is a venture capital firm with a strong focus on early-stage technology startups in the Baltic Sea region. Established in 2003, the firm has carved out a niche in sectors like B2B software, digital health, robotics, and automation. With a global perspective, Imprimatur helps startups with scalable business models reach international markets. The firm typically invests between €200k and €2 million in companies that have demonstrated initial revenue, particularly those with a minimum of €5,000 MRR. Imprimatur’s team operates from offices in Riga, London, and Singapore, bringing deep expertise in engineering, life sciences, entrepreneurship, and finance to the table. This diverse skill set enables the firm to provide more than just capital; they offer strategic guidance to ensure startups achieve sustainable growth. Imprimatur’s investment strategy is built on identifying ambitious founders with innovative solutions that address significant market needs. Their portfolio includes over 70 startups, such as Anatomy Next, which has successfully scaled with their support. Although their current fund is fully invested, Imprimatur continues to maintain a strong presence in the venture capital ecosystem, focusing on driving technological advancements that have the potential to impact industries globally. Their commitment to fostering innovation is evident in their active involvement in the startups they back, providing long-term support that goes beyond initial funding to include mentorship, market access, and business development expertise.

Incisive Ventures is a venture capital firm based in Seattle, Washington, founded by Martin Tobias. The firm focuses primarily on pre-seed and seed-stage investments, targeting transformative founders who are working on high-impact, innovative projects. Incisive Ventures has a strong emphasis on sectors such as artificial intelligence (AI), data, SaaS, fintech, and marketplaces. The firm is known for its deep engagement with founders, providing not just capital but also strategic advice and operational support. Incisive Ventures is particularly interested in identifying and supporting startups that demonstrate strong growth potential and the ability to scale efficiently. They maintain a high-conviction, low-volume investment strategy, working closely with a select number of companies to ensure they have the best chance of success. Incisive Ventures also places a significant focus on evaluating startups based on their team dynamics, market size, go-to-market strategies, competition, and unit economics, as discussed in their various insights and webinars. The firm prides itself on being a partner for growth, offering tailored support to help startups navigate the complex early stages of their development​.

INCO Ventures, part of the INCO Group, is a venture capital firm based in Paris, France, specializing in impact investing. Founded in 2011, INCO Ventures focuses on backing startups that drive social and environmental change. The firm manages over €500 million across various funds, including direct management of €110 million and advisory roles for additional funds totaling €450 million. INCO Ventures invests in companies that are shaping a more inclusive and sustainable economy. Their portfolio includes more than 100 impact companies across diverse sectors, such as energy, ecological transitions, digital economy, education, and healthcare​​. They ensure a triple return on investment—economic, social, and environmental—measured using their unique impact assessment tool, INCO Ratings. The broader INCO Group is dedicated to advancing economic opportunities and supporting impact entrepreneurs through initiatives like INCO Academy, INCO Entrepreneurs, and INCO Spaces, which provide skilling programs, support for underrepresented founders, and co-working spaces respectively​.

Incubit Ventures is a deep tech accelerator and incubator based in Beer Sheva, Israel. Founded in 2012, it operates as a subsidiary of Elbit Systems, one of Israel's leading technology firms. Incubit Ventures is focused on investing in early-stage startups that are working on highly innovative and disruptive technologies, particularly those with strong scientific foundations. The firm is part of the Israeli Innovation Authority’s incubators program, providing about $1 million in funding to each startup during the first two years of their development. In addition to financial support, Incubit Ventures offers startups access to Elbit Systems’ extensive resources, including R&D facilities, labs, and expert mentorship. The program is designed to help these startups navigate the complex journey from concept to market-ready products, particularly in industries such as aerospace, healthcare, energy, and advanced materials. Incubit Ventures has a portfolio of over 26 investments, which include companies like NewRocket, developing environmentally friendly rocket engines, and GreenVibe, which is innovating in real-time concrete monitoring technology. The firm aims to bridge the gap between the flexibility of startups and the strength of a large corporate entity, leveraging its connection with Elbit Systems to help these companies achieve commercial success.

Index Ventures is a renowned venture capital firm with dual headquarters in San Francisco and London. Founded in 1996, the firm has a strong track record of investing in transformative companies across various sectors including technology, fintech, healthcare, and consumer products. Notable investments by Index Ventures include some of the biggest names in tech and business today. These include Dropbox, Figma, Slack, Roblox, Adyen, and Deliveroo. The firm has been instrumental in the growth of these companies, providing both financial backing and strategic support​. Index Ventures has raised several significant funds to support its investment strategy. Recently, they closed $3.1 billion in new funds, which are spread across early-stage, growth-stage, and seed-stage investments. This substantial capital allows them to back innovative startups from inception through to maturity​. The firm is known for its deep commitment to the entrepreneurs they support, emphasizing close partnerships and long-term growth. This approach has made Index Ventures a preferred partner for visionary founders looking to scale their businesses globally​.

ING is a global financial institution with a strong focus on sustainable investment, exemplified by initiatives like the world's first sustainability improvement fund. This fund encourages companies to enhance their ESG performance by linking financing terms to sustainability goals. ING collaborates with venture capitalists such as SmartFin, specializing in financial technologies, to support innovation in the fintech sector. The firm has actively divested non-core assets, such as the sale of ING Life Korea to MBK Partners, to streamline its operations and focus on core banking activities. This strategic shift supports ING's broader goal of fostering sustainable development across its investment portfolio. ING's private equity engagements reflect its commitment to environmental and social governance, supporting businesses that align with their sustainability ethos. This approach not only helps ING achieve attractive returns but also contributes positively to global sustainability efforts.

InMotion Ventures is the venture capital arm of Jaguar Land Rover (JLR), focusing on early-stage investments that align with JLR's strategic goals. Established as a key component of JLR’s Open Innovation programme, InMotion Ventures supports startups from Pre-seed to Series A stages in sectors such as climate tech, industrial technology, and enterprise solutions. Their investments aim to accelerate JLR's Reimagine strategy, which focuses on sustainability and innovation in luxury vehicles and services. The fund offers startups not just capital, but also access to a rich ecosystem of innovators and the broader resources of JLR and Tata Group. This includes partnership opportunities, domain expertise, and significant exposure, helping startups gain a competitive edge and achieve growth. InMotion Ventures' portfolio includes companies like Ascend Elements, which focuses on lithium-ion battery recycling, and ev.energy, which connects electric vehicles to grid networks for greener and more efficient charging. Their investment strategy emphasizes supporting technologies that contribute to a sustainable future.

Innovation Works (IW) is a leading early-stage investor in southwestern Pennsylvania, primarily focused on technology startups. Founded as part of the Ben Franklin Technology Partners network, IW has significantly contributed to the region's economic growth by investing in over 700 companies, which have collectively raised $3.3 billion in follow-on funding and created over 20,000 jobs. Notable sectors in IW's portfolio include robotics, life sciences, software, and clean energy. Some of their prominent investments are in companies like Aurora Innovation and Stack AV, which are part of the thriving robotics and autonomous vehicle industries in Pittsburgh. IW's support extends beyond funding, providing mentorship and resources through their accelerators, AlphaLab and AlphaLab Gear. In 2023, despite a national downturn in venture capital, Pittsburgh's tech sector saw a substantial increase in investments, reaching $3.12 billion, driven by significant activity in automation and AI. This positions Pittsburgh as an emerging tech hub with a growing number of new investors and global technology companies setting up satellite offices in the region. For startups looking to connect with IW, demonstrating innovation and potential for significant impact in high-opportunity markets will align with IW’s investment philosophy.

Insight Partners, founded in 1995 and headquartered in New York City, is a global venture capital and private equity firm renowned for investing in high-growth technology, software, and internet companies. The firm has a vast portfolio of over 1,600 investments, including notable companies like Calm, monday.com, WalkMe, and Checkout.com​. The firm is particularly known for its significant investments across various sectors such as IT infrastructure, cybersecurity, fintech, e-commerce, and DevOps. In 2022, Insight Partners closed its largest fund to date, raising over $20 billion, which underscored its aggressive investment strategy and commitment to high-growth companies​​. Insight Partners employs a hands-on approach to supporting its portfolio companies, offering extensive resources through its Onsite team. This team comprises over 130 experts in areas like sales, marketing, product development, and talent acquisition, dedicated to helping companies scale efficiently. This support has been crucial in helping many of their portfolio companies achieve significant growth and successful exits​. Overall, Insight Partners' combination of substantial financial resources, strategic support, and industry expertise positions it as a leading player in the global venture capital landscape​.

InterWest Partners, established in 1979, is a venture capital firm focused on early-stage investments in the information technology and healthcare sectors. Based in Menlo Park, California, the firm has raised over $2.8 billion across ten funds. Throughout its history, InterWest has backed more than 250 companies, achieving 97 IPOs and participating in 95 acquisitions. InterWest Partners IX, one of their notable funds, closed at $606 million and primarily invests in early-stage companies within its targeted sectors. The firm is known for its successful investments in companies such as Doximity, Canva, Braze, and Glaukos. InterWest's approach focuses on partnering with world-class entrepreneurs to build leading companies in IT and healthcare, supporting them through various growth stages. While InterWest Partners is not currently seeking new investments, their legacy includes influential early wins in companies like Xilinx and CIENA in the IT sector, and COR Therapeutics and Ventritex in healthcare, cementing their reputation as a key player in the venture capital landscape.

Inventages Venture Capital, founded in 2000 by Gunnar Weikert, is the venture capital arm of Nestlé, headquartered in Nassau, Bahamas. The firm specializes in health care, life sciences, pharmaceuticals, cosmeceuticals, enabling technologies, and medical devices. Inventages has a broad investment focus, participating in seed, early, mid, and late-stage ventures. Notable investments include Accera, a biotechnology firm focused on therapies for neurodegenerative diseases, and Phagenesis, which develops treatments for dysphagia. Other significant investments are Shield Therapeutics, known for its iron deficiency treatments, and Cognoptix, which is developing diagnostics for Alzheimer's disease​. Inventages typically invests with an average round size of $14 million, demonstrating a strong commitment to substantial funding rounds. The firm is actively involved in guiding its portfolio companies through strategic growth and development stages. Key team members include Gunnar Weikert (Founder and CEO), Thomas Bayerl, and Wolfgang Reichenberger, all bringing significant expertise in venture capital and life sciences to the table. Inventages is particularly noted for its rigorous due diligence process and a strong focus on the commercial viability of scientific innovations. This approach has enabled them to support groundbreaking developments in health and wellness sectors​.

Invesco Private Capital, a division of Invesco, specializes in a broad range of investments, including early-stage ventures, growth capital, buyouts, and private equity. With over 25 years of experience, they leverage a deep network of industry relationships and extensive market insights to identify and support high-potential startups and emerging private equity managers​. Invesco’s notable investments span across various sectors, including technology, healthcare, and financial services. They have been involved in significant ventures and direct investments that align with their strategy of partnering with innovative and scalable companies. Their comprehensive approach includes not only capital investment but also strategic support and operational expertise to help portfolio companies achieve sustainable growth. For more information on their investment strategies and portfolio, you can visit the Invesco website or explore their detailed profiles on investment platforms like PitchBook and Crunchbase.

iSelect Fund is a St. Louis-based venture capital firm focusing on early-stage investments in sectors that have a profound global impact, such as agriculture, food, and healthcare. They invest in companies addressing critical challenges like sustainable food production, improved healthcare delivery, and innovations that enhance human health through better nutrition. iSelect’s portfolio includes over 60 companies, such as Harpe Bioherbicide and Kula Bio, which are tackling sustainability in agriculture through natural and biotechnological solutions. The firm operates with an evergreen fund structure, offering ongoing investment opportunities with low minimums, making venture capital more accessible to accredited investors. Their investment strategy revolves around a balanced, diversified portfolio approach, which allows them to spread risk while supporting transformative companies. iSelect focuses on startups that leverage data, technology, and science to drive innovation, particularly in the areas of food systems, agtech, and health tech. Their emphasis on impact investing means they are highly selective, looking for businesses with the potential for significant financial returns as well as positive societal outcomes. They typically avoid sectors like cannabis and direct-to-consumer models, and focus on companies that can create long-term, scalable change.

Island Capital Partners is an early-stage venture capital firm based in Prince Edward Island, Canada. Founded in 2017, the firm primarily focuses on pre-seed and seed-stage investments, occasionally making pre-pre-seed investments. With a check size ranging from $50K to $500K, Island Capital invests primarily in Atlantic Canada, helping startups across sectors like enterprise software, AgTech, energy, sustainability, and medical devices. As operational investors, Island Capital takes a hands-on approach, actively supporting startups in setting up and scaling their businesses. Some of the notable companies in their portfolio include Coloursmith Labs, Symbodi, and Woveo, reflecting their diverse investment strategy. Island Capital Partners is currently investing through its second fund, continuing its mission to back promising early-stage companies in the region. The firm’s team, which includes partners like Alex MacBeath, Ron Myers, and Katie Arsenault, is dedicated to building strong relationships with founders and providing operational guidance alongside capital​.

Joule Ventures, formerly Janvest Capital Partners, is a seed-stage venture fund specializing in Israeli startups commercializing enterprise-grade solutions for the U.S. market. Their notable investments include BioCatch, a leader in behavioral biometrics, and Coralogix, a provider of AI-driven log analytics. Joule's focus spans DevOps, cybersecurity, fintech, AI/ML, data enablement, and enterprise software. Geographically, they target startups in Israel with a strategic expansion to North America. The fund's strategy emphasizes a partner-only approach, providing founders with direct access to decision-makers and high-level resources from the initial engagement through to commercialization. Joule Ventures typically leads funding rounds and offers an average check size of $1M-$3M, demonstrating a strong commitment to early-stage startups. Key team members include Brian Rosenzweig in Atlanta, Dafna Winocur Biran in Tel Aviv, and Daniel Frankenstein in New York. Brian brings two decades of experience in Israel’s venture market, Dafna offers deep expertise in both Israeli and U.S. markets, and Daniel leverages his background in corporate advisory to support portfolio companies. Startups can approach Joule Ventures through their streamlined process, ensuring efficient support from the first interaction. Their offices in Tel Aviv, New York, and Atlanta facilitate a robust network and resource base for ambitious Israeli founders aiming to penetrate the U.S. enterprise market​.

Javelin Venture Partners is a venture capital firm based in San Francisco, established by experienced entrepreneurs. The firm focuses on early-stage investments, primarily in the late seed and early Series A rounds, with initial check sizes ranging from $500K to $4M. Their investment strategy is geared towards software and technology companies with substantial growth potential and innovative business models. Javelin Venture Partners has a diverse portfolio, including companies like MasterClass, Thumbtack, SmartAsset, and Niantic. They seek founders who exhibit relentless grit, are data-driven, and possess exceptional recruiting and fundraising skills. The firm's evaluation criteria emphasize dynamic and capable founders, capital-efficient business models, and large market opportunities. The leadership team includes Managing Directors Jed Katz and Noah J. Doyle. Jed Katz has a rich history in online commerce and has founded multiple companies. He serves on the boards of Thumbtack, SmartAsset, HighArc, and others. Noah J. Doyle has extensive experience in product management and business development, having directed enterprise products at Google Earth and Google Maps. He sits on the boards of Appvance, Armory, Estimote, and others.

JetBlue Ventures is dedicated to investing in early-stage startups that are transforming travel, hospitality, and transportation. Their primary focus areas include next-generation aviation operations, seamless customer journeys, innovative accommodations, loyalty and revenue optimization, and sustainable travel solutions. JetBlue Ventures aims to enhance the end-to-end travel experience and bring humanity back to travel on a grand scale. Their portfolio includes notable companies such as Joby Aviation, which is pioneering electric vertical takeoff and landing (eVTOL) aircraft, and Tomorrow.io, a weather technology company providing precise weather predictions to improve operational efficiencies in aviation. Other investments include FLYR, a SaaS platform for airline revenue management, and Transparent, a market intelligence company for vacation rentals​. JetBlue Ventures typically leads investment rounds and provides an average check size suited for early-stage funding. They also offer extensive support beyond financing, including community building, marketing assistance, business development, financial planning, and administrative support through their dedicated platform for portfolio companies​. The team, led by President Amy Burr, leverages deep expertise in aviation and hospitality, coupled with a strong focus on fostering innovation and helping startups scale. Burr's strategic direction has been pivotal in integrating successful startup programs into JetBlue's broader corporate innovation initiatives​.

iangmen Ventures, established in 2015, is an early-stage venture capital firm based in Beijing, China. The firm focuses on investing in tech-driven startups, particularly those in sectors such as artificial intelligence, healthcare, IoT, and enterprise computing. Their strategy revolves around leveraging technological innovation to unlock business value, primarily targeting early-stage companies that show significant growth potential. Jiangmen has invested in over 50 startups across various industries, including notable companies like Hesai Technology and Heisenberg Robotics. The firm is known for its commitment to backing companies involved in frontier technology such as quantum computing, AI-powered platforms, and advanced manufacturing. One of its more recent investments includes MyTwins.ai, a Hangzhou-based AI platform. Co-founded by Vanessa Gao and Qiang Shen, Jiangmen Ventures takes a hands-on approach with portfolio companies, offering not only financial backing but also strategic mentorship to help startups scale effectively. The firm places a strong emphasis on innovative solutions that can disrupt traditional industries and foster industrial upgrades, particularly in China’s rapidly growing tech landscape.

Johnson & Johnson Innovation is a global network dedicated to empowering healthcare innovators. Founded in 2012, JLABS supports early-stage companies in the pharmaceutical, medical device, consumer, and health tech sectors. Their mission is to foster the development of life-saving and life-enhancing health solutions. JLABS operates across multiple locations, including San Diego, San Francisco, Cambridge, Shanghai, and New York. They offer a robust infrastructure and resources to startups, facilitating collaboration and growth. The initiative has made over 400 investments, including notable companies such as Capstan Therapeutics and Synthis Therapeutics, focusing on biotechnology and medical devices. Their investment strategy emphasizes strategic partnerships and co-investments, working alongside various industry leaders and funding bodies to maximize impact. Recent investments include support for companies like Immunyx, Grapheal, and Neurogene, showcasing their commitment to advancing innovative healthcare solutions.

Jolt Capital is a Paris-based private equity firm specializing in growth-stage investments in deeptech companies across Europe. Founded in 2011, Jolt focuses on supporting technology-rich firms with strong fundamentals, particularly in sectors like photonics, advanced materials, semiconductors, artificial intelligence, and IoT. They typically invest between €10 million and €50 million in businesses that are poised for significant scale, offering both capital and operational expertise to help them expand globally. Jolt Capital stands out by using its proprietary AI platform, Jolt.Ninja, to identify promising investment opportunities. This technology-driven approach allows the firm to discover high-potential companies while avoiding market hype. Their portfolio includes notable companies like Heptagon, NIL Technology, and Verimatrix, all of which leverage cutting-edge technology to address significant market needs. The team at Jolt Capital combines decades of experience in technology, investment, and entrepreneurship, working hands-on with portfolio companies to assist in everything from business strategy to talent acquisition and financial optimization. With a focus on sustainable and responsible investment, Jolt Capital’s mission is to grow European deeptech firms that can transform industries and improve societal outcomes.

Joule Ventures, formerly known as Janvest Capital Partners, is a U.S.-based seed fund focused on investing in Israeli founders who are commercializing enterprise-grade solutions for the U.S. market. The firm, which recently closed a $65 million Fund IV, operates from offices in Tel Aviv, New York, and Atlanta. The firm emphasizes hands-on, high-conviction investments in pre-seed and seed stage companies, particularly in sectors like cybersecurity, AI/ML, fintech, DevOps, data enablement, and software. Notable investments include BioCatch, a leader in behavioral biometrics, and Coralogix, a company providing full-stack observability solutions. Joule Ventures has also backed emerging companies such as Mirato, an AI-driven TPRM platform for financial institutions, and Arnica, a stealth-mode DevSecOps startup. Joule Ventures stands out for its comprehensive support system, offering U.S. market validation, design partner engagement, early customer connections, core team recruitment, cap table and corporate governance guidance, Series A acceleration, and branding and PR support. This extensive involvement helps ensure that their portfolio companies are well-equipped for success in the competitive U.S. enterprise market​.

Jovono Ventures, based in Los Angeles and founded in 2016, is a venture capital firm that focuses on investing in paradigm-shifting companies and missionary founders who tackle hard problems or create delightful products. Their portfolio reflects a diverse range of industries, particularly high-tech and enterprise applications. Some of Jovono's notable investments include Anduril Industries, a provider of AI-based defense solutions; Flexport, a digital freight forwarding platform; and DoNotPay, a legal tech company that helps users navigate legal paperwork. Other significant investments are in companies like Sofar Ocean Technologies, QEDIT, and Paragon​. Jovono's investment strategy does not limit itself to specific stages, locations, or industries, but rather focuses on the potential impact and innovation of the companies. This flexibility allows them to back transformative startups at various stages of development. They have made 23 investments so far, including in early-stage companies such as Persist AI and Apollo Brokers. The firm is led by Evan Zimmerman, who brings extensive experience and a strong vision for supporting groundbreaking ventures. Jovono's commitment to building long-term partnerships with founders and helping them navigate their growth journeys sets it apart in the venture capital landscape.

Joy Ventures, now rebranded as Corundum Neuroscience, is a venture capital firm originally founded in 2017 and based in Herzliya, Israel. The firm has transitioned its focus to become a neuroscience-focused venture builder and fund. Under its new identity, Corundum Neuroscience aims to drive innovation in neuroscience by investing in and supporting early-stage companies that develop groundbreaking consumer products and technologies rooted in scientific research. The firm specializes in nurturing startups at various stages, from seeding ideas to advancing them through the critical phases of development. Corundum Neuroscience emphasizes creating products that enhance emotional and mental well-being, reflecting its deep commitment to improving human health through innovative technologies. The firm’s strategy includes providing not just financial backing but also extensive resources such as mentorship, strategic guidance, and access to a network of experts in neuroscience and related fields. With its rebranding, Corundum Neuroscience is positioned to become a leader in the neuroscience sector, fostering the development of cutting-edge solutions that address some of the most pressing challenges in mental health and cognitive sciences.

Kairos Ventures, established in 2015 and headquartered in Beverly Hills, California, is a venture capital firm focused on investing in early-stage companies across life sciences, physical sciences, and technology sectors. The firm partners with leading scientists and universities to commercialize groundbreaking discoveries. Their portfolio includes notable companies like MemVerge, which aims to merge computer memory and storage using non-volatile RAM, and Neuro-Bio, a biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. Another significant investment is MixComm, a developer of advanced 5G mmWave chips that enhance the efficiency and range of 5G base stations, which was acquired by Sivers Semiconductors in 2022. Kairos Ventures has made over 81 investments and achieved several exits, including Actinobac Biomed and MixComm. The firm is led by founder and CEO James Demetriades, along with a team of experienced professionals who provide strategic support to their portfolio companies.

Katalyst Ventures is a multi-stage venture capital firm that focuses on Applied AI across several sectors, including digital health, enterprise SaaS, and autonomous logistics. Founded by Susan Choe, the firm aims to invest in companies that leverage AI to transform analog processes into scalable, data-driven solutions. Their investment philosophy is centered on supporting businesses that can harness predictive algorithms to drive efficiency and innovation across large markets. The firm's portfolio includes notable companies such as Zipline, which uses drone technology for autonomous deliveries, and Arine, a digital health platform optimizing medication management through AI. Katalyst Ventures typically invests from early to growth stages, offering not just capital but strategic support to help startups scale their operations. Their hands-on approach ensures that startups receive guidance on technology, business development, and international expansion. Katalyst's approach to investing in AI-driven businesses reflects a belief in the transformative potential of data and algorithms, akin to previous technological waves like the internet and mobile. With a focus on practical applications that improve everyday operations, they seek to foster startups that can offer borderless, scalable business models.

Kinnevik is a leading investment company founded in 1936, known for its focus on digital consumer businesses. The firm primarily invests in healthcare, software, marketplaces, and climate tech, partnering with innovative entrepreneurs to drive change and improve the way we work, live, and play. Kinnevik’s portfolio includes over 30 companies, such as Cityblock, Mews, Pleo, and Recursion. Kinnevik operates with a long-term investment horizon, providing substantial support to its portfolio companies from early-stage to growth-phase. The firm emphasizes sustainability and believes in investing in business models that generate significant returns while promoting environmental and social responsibility. The executive team is led by CEO Georgi Ganev, with Samuel Sjöström recently appointed as Chief Strategy Officer. The team includes professionals with deep expertise across various sectors, dedicated to fostering the growth of pioneering companies. Kinnevik's investment approach combines financial backing with active involvement in the strategic direction of its portfolio companies, leveraging nearly a century of investment expertise to build successful, sustainable businesses.

Kitchen Fund is a growth equity firm based in New York that specializes in investing in the restaurant and foodservice sectors. Founded in 2016 by Dan Rowe and Gregory Golkin, the fund focuses on partnering with visionary food and beverage brands that are redefining dining experiences. Kitchen Fund’s investment strategy centers around supporting brands with strong unit economics, authentic brand stories, and the potential for scalable growth. The fund provides not just capital but also strategic guidance in areas such as team building, market expansion, financial analysis, and ESG (Environmental, Social, and Governance) initiatives. Their portfolio includes well-known names like DIG, Miscusi, and Gregorys Coffee, highlighting their commitment to backing brands that are both innovative and culturally resonant. Kitchen Fund places a strong emphasis on authenticity and social impact, seeking out brands that weave the founder's vision into every aspect of the customer experience. They believe that sustainable practices and a strong connection to customers and communities are critical for long-term success​.

KKR, a global investment giant established in 1976, boasts a diverse and robust portfolio. Among their notable tech investments are GoDaddy, FanDuel, and BMC Software, while in energy and healthcare, they back EP Energy, Ridge Natural Resources, BridgeBio Pharma, and Coastal Carolina Hospital. Their industry focus is broad, spanning private equity, infrastructure, real estate, and credit, with a strong emphasis on sustainability and long-term value creation. Geographically, KKR's investments stretch across the Americas, Europe, and Asia Pacific, reflecting their global reach. Their strategy emphasizes patient, disciplined investing, leveraging deep industry knowledge and a network of expert resources to drive growth in their portfolio companies. They are known for leading investment rounds and typically target companies with substantial growth potential and innovative capabilities. KKR often writes large checks, frequently exceeding $100 million, and takes an active role in guiding their investments, offering strategic advice and operational support. Companies looking to attract KKR's interest should highlight their growth potential, solid business models, and alignment with KKR’s strategic objectives. The firm’s leadership includes Henry Kravis and George Roberts, who bring decades of investment expertise and are based in New York. KKR’s team of over 750 investment professionals worldwide ensures that each investment benefits from specialized expertise and strategic insights. For startups and businesses, aligning proposals with KKR’s focus on sustainable growth and value creation is key to engaging successfully with this investment powerhouse.

Kleiner Perkins, based in Menlo Park, California, is one of Silicon Valley’s most storied venture capital firms, known for its early investments in groundbreaking technology companies. Founded in 1972, the firm has backed over 900 ventures, including iconic names like Amazon, Google, and Genentech​. Kleiner Perkins invests primarily in early-stage companies across a broad range of industries including technology, healthcare, and sustainability. Their investment strategy is characterized by partnering closely with founders from the inception of their companies through to IPO and beyond. This approach has led to successful exits such as Netscape, Cerent, and more recently, Google and Amazon​. The firm has seen significant leadership changes in recent years, with the addition of partners like Mamoon Hamid and Ilya Fushman, who have driven a renewed focus on early-stage investments. Recent funds include the $700 million KP19 and the $750 million KP Select fund, which aim to support high-growth companies in sectors like enterprise software, consumer tech, and fintech​. Kleiner Perkins continues to leverage its deep network and extensive experience to support its portfolio companies in areas such as talent acquisition, go-to-market strategies, and marketing. This hands-on approach, combined with their strategic investments, ensures they remain a key player in fostering innovation and driving growth in the tech ecosystem.

Kli Capital, formerly known as BNSG Capital, is a venture capital firm founded in 2014 by Shmuel Gniwisch. Based in New York, the firm focuses on investing in early-stage startups across the U.S., Israel, and emerging markets. Kli Capital targets sectors including healthtech, insurtech/fintech, and consumer products. The firm has made 79 investments and has seen 18 exits. Notable portfolio companies include Hippo Insurance, Imagen Technologies, mPharma, Nym Health, and Cycognito. Kli Capital has recently closed its third fund, aiming to invest $750k to $1.5 million in pre-seed and seed-stage companies. This new fund emphasizes the firm's strategy of backing ambitious founders and providing comprehensive support beyond financial capital. Kli Capital's team includes key figures such as founder and managing partner Shmuel Gniwisch and partner Elias Davis. The firm prides itself on its hands-on approach, leveraging its operational experience to help startups achieve significant growth and success.

Alantra is a prominent international financial services firm offering a range of investment banking and alternative asset management services. Their venture capital focus includes managing funds like the €210 million Klima Energy Transition Fund, which supports innovative energy-tech companies aimed at accelerating the energy transition and combating climate change. This fund, alongside their Solar Fund, underscores Alantra's commitment to sustainable and impactful investments. Alantra's venture capital activities span Europe and North America, targeting high-growth, scalable businesses in sectors like energy transition, cybersecurity, and life sciences. The firm typically invests €8-12 million initially, with the potential to commit up to €21 million per company across follow-on rounds. They prioritize companies with seasoned management teams, proven technologies, and clear commercial traction. The firm boasts a diverse team of professionals based across key European cities, including Madrid, Paris, Bonn, and London, who bring extensive experience in the energy sector and other specialized industries. This expertise is leveraged to provide comprehensive support to their portfolio companies, helping them scale and succeed in competitive markets. Alantra's commitment to responsible investment is highlighted by their compliance with the EU Sustainable Finance Disclosure Regulation and their membership in the Principles of Responsible Investing (PRI). This aligns their interests with those of their investors, fostering sustainable and long-term growth. For startups looking to approach Alantra, highlighting innovative solutions within their focus areas and demonstrating strong market potential will resonate well with their investment strategy​

Kohli Ventures, led by Tej Kohli, is a London-based investment firm with a focus on transformative technologies that drive exponential growth. The firm primarily backs growth-stage ventures in sectors like artificial intelligence, robotics, biotech, e-commerce, and esports, aiming for both high returns and significant social impact. Recent notable investments include biotechnology firm Detraxi and tech giant SpaceX, reflecting its commitment to cutting-edge innovations with global potential. Kohli Ventures prefers control-oriented investments, often acting as the lead or sole investor, allowing founders to focus on scaling rather than continuous fundraising. Their strategy targets companies with a clear path toward an IPO, and they are known for swift decision-making and high liquidity. The firm is particularly active in emerging markets across Asia, Africa, and Latin America. The investment team is anchored by Tej Kohli, whose expertise spans both venture capital and philanthropy. Kohli’s vision extends beyond financial returns, with the fund supporting ventures that can improve lives globally, embodying a double bottom line approach that blends commercial success with humanitarian impact.

Kompas VC is an early-stage venture capital firm that focuses on investing in technologies that drive digital transformation and decarbonization within the building and manufacturing industries. Established in 2021, Kompas VC has offices in Amsterdam, Berlin, Copenhagen, and Tel Aviv. The firm typically invests between €1 million and €5 million in Seed and Series A rounds, continuing to support its portfolio companies throughout their lifecycle. Kompas VC's investment strategy centers on three primary sectors: the built environment, manufacturing, and climate technology. They back innovative startups that aim to reduce carbon emissions, improve energy efficiency, and promote sustainable practices in construction and manufacturing. Their portfolio includes companies like CyanoCapture, which focuses on low-energy carbon capture technology, and Material Evolution, which produces low-carbon cement from industrial waste. The firm is driven by a mission to support the most talented entrepreneurs who are committed to creating a zero-emission, zero-waste building and manufacturing industry. Kompas VC also provides strategic guidance, mentorship, and access to a robust network to help their portfolio companies succeed in competitive markets.

Korify Capital, based in Basel, Switzerland, focuses on early and growth-stage investments in the biotech sector, particularly targeting longevity and mental health. Launched by Robin and Peter Lauber’s family office, Infinitas Capital, Korify Capital aims to drive forward breakthrough technologies that can extend healthy lifespan and address mental health issues. Notable investments include Alto Neuroscience, which uses AI-derived brain biomarkers to develop psychiatric treatments, and Cambrian Biopharma, which is pioneering therapeutics to lengthen healthspan by targeting the biological drivers of aging. Another significant investment is Gameto, which focuses on improving assisted fertility and tackling ovarian aging through cellular reprogramming. Korify Capital also invests in companies like Refoxy, which develops medicines to treat age-related diseases by modulating stress response pathways, and Rejuveron, a biotech firm aiming to transform aging-related scientific discoveries into practical treatments. These investments demonstrate Korify’s commitment to supporting innovative approaches in the biotech field, aiming to enhance longevity and overall health. The firm’s strategy involves leveraging its extensive venture capital network and deep expertise in biotech to support these transformative companies, helping them achieve significant milestones and growth.

Lauxera Capital Partners is a healthcare-focused investment firm, specializing in growth-stage companies that are scientifically de-risked and have clear commercial pathways. Founded in 2020, the firm operates from Paris and San Francisco, with a focus on innovative healthcare sectors like medical devices, digital health, diagnostics, life sciences tools, and healthcare IT. They invest when startups have a proven revenue model and are ready to scale, contributing both capital and strategic expertise. Lauxera manages over €260 million through its Lauxera Growth I fund and typically invests between €300,000 and €3 million per startup. The firm is known for its hands-on approach, leveraging the operational experience of its team to support management in overcoming growth challenges and optimizing market adoption. Notable investments include Natural Cycles and Caresyntax, highlighting their commitment to cutting-edge health technologies​. Lauxera’s global perspective and strong European roots, combined with its healthcare expertise, make it a valuable partner for startups aiming to scale in large healthcare markets​.

Lead Edge Capital is a growth equity firm managing over $5 billion in assets, with a focus on software, internet, and tech-enabled businesses. The firm invests in both private and public companies, typically deploying between $25 million and $300 million. Notable portfolio companies include Alibaba, Toast, Grafana, and Wise, showcasing a strong track record across diverse sectors. The firm’s strategy revolves around leveraging its extensive network of 700+ executives and industry leaders to drive growth through strategic partnerships and customer acquisition. Lead Edge is highly flexible, offering both minority and buyout investments to companies with $10 million+ in revenue and 25%+ year-on-year growth. Geographically, Lead Edge operates from New York and Santa Barbara but invests globally. They typically engage in late-stage funding rounds, often as co-investors, and aim to bring more than just capital to the table. Founders benefit from Lead Edge’s vast network, which is a key part of their value proposition. The team is led by professionals like Evan Skorpen (Partner, Public Markets), with deep expertise in tech and finance. Startups looking to engage should focus on demonstrating scalable growth and recurring revenue models to catch their attention.

Leaps by Bayer, founded in 2015, is Bayer AG's strategic impact investment unit focusing on transformative biotechnologies in health and agriculture. Since its inception, Leaps by Bayer has invested over $1.9 billion in more than 60 ventures, targeting significant challenges through ten key "leaps" designed to address pressing global issues. Key investments include Recursion Pharmaceuticals, which focuses on drug discovery using AI, and BlueRock Therapeutics, a company specializing in cell therapy. These investments align with their strategic goals such as curing genetic diseases, developing sustainable organ and tissue replacements, and reducing the environmental impact of agriculture. Leaps by Bayer's portfolio companies operate autonomously, but benefit from Bayer’s active incubation model, which provides resources and strategic guidance. This approach helps them focus on long-term, high-impact results rather than short-term gains. Leaps by Bayer also collaborates globally with partners in industry, academia, and civil society to drive these innovations forward.